European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
Age at first full-term pregnancy and mammographic breast density in postmenopausal women: a systematic review
Age at first full-term pregnancy and mammographic breast density in postmenopausal women: a systematic review
DOI: 10.22514/ejgo.2023.016
Does gas insufflation during oncologic laparoscopic surgery cause dissemination of malignant cells?
Does gas insufflation during oncologic laparoscopic surgery cause dissemination of malignant cells?
DOI: 10.22514/ejgo.2023.017
Risk factors of lymph node metastasis in patients with type II endometrial carcinoma: a retrospective signle-center study
Risk factors of lymph node metastasis in patients with type II endometrial carcinoma: a retrospective signle-center study
DOI: 10.22514/ejgo.2023.018
Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study
Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study
DOI: 10.22514/ejgo.2023.019
HTR7 and its N6-methyladenosine modification: a potential target in cell cycle regulation of cervical cancer
HTR7 and its N6-methyladenosine modification: a potential target in cell cycle regulation of cervical cancer
DOI: 10.22514/ejgo.2023.020
Comparison of survival outcomes following radiotherapy versus radical hysterectomy in patients with stage IIA cervical squamous cell carcinoma
Comparison of survival outcomes following radiotherapy versus radical hysterectomy in patients with stage IIA cervical squamous cell carcinoma
DOI: 10.22514/ejgo.2023.021
Characteristics and prognosis of young breast cancer patients with low expression of estrogen receptor
Characteristics and prognosis of young breast cancer patients with low expression of estrogen receptor
DOI: 10.22514/ejgo.2023.022
Identification of ferroptosis-related risk signature and correlation with the overall survival of ovarian cancer
Identification of ferroptosis-related risk signature and correlation with the overall survival of ovarian cancer
DOI: 10.22514/ejgo.2023.023
N6-methyladenosine-related genes contribute to malignant progression, have clinical prognostic and neoadjuvant treatments response impact for breast cancer
N6-methyladenosine-related genes contribute to malignant progression, have clinical prognostic and neoadjuvant treatments response impact for breast cancer
DOI: 10.22514/ejgo.2023.024
Enhanced recovery after surgery (ERAS) protocols in patients with advanced ovarian cancer undergoing ultra-radical cytoreductive surgery with intestinal resection and anastomosis: a retrospective study
Enhanced recovery after surgery (ERAS) protocols in patients with advanced ovarian cancer undergoing ultra-radical cytoreductive surgery with intestinal resection and anastomosis: a retrospective study
DOI: 10.22514/ejgo.2023.025
Clinical value of multidisciplinary collaborative nursing model for breast cancer and its preventive effects on postoperative lymphedema
Clinical value of multidisciplinary collaborative nursing model for breast cancer and its preventive effects on postoperative lymphedema
DOI: 10.22514/ejgo.2023.026
S100A7 promotes endometrial carcinoma progression by activating the MAPK signaling pathway
S100A7 promotes endometrial carcinoma progression by activating the MAPK signaling pathway
DOI: 10.22514/ejgo.2023.028
Radiation associated angiosarcoma of the breast: a pictorial review of eleven cases highlighting a devastating complication of breast radiotherapy
Radiation associated angiosarcoma of the breast: a pictorial review of eleven cases highlighting a devastating complication of breast radiotherapy
DOI: 10.22514/ejgo.2023.029
Immunohistological study of ovarian mature cystic teratoma with extremely elevated SCC antigen level
Immunohistological study of ovarian mature cystic teratoma with extremely elevated SCC antigen level
DOI: 10.22514/ejgo.2023.030
Seminar of Gynecological Oncology of the International Conference on Psychiatry and Neurorestoratology (ICPN2022) Ⅱ
Seminar of Gynecological Oncology of the International Conference on Psychiatry and Neurorestoratology (ICPN2022) Ⅱ
DOI: 10.22514/ejgo.2023.031
Published Ahead of Print
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Advanced Decision Support Systems for Efficient Diagnosis of Gynaecological Cancers
Keywords: Computational and Mathematical Methods; Gynaecological Cancers; Machine Learning; Optimization Algorithms
Editor: Liaqat Ali, PhD
Submission deadline: 31 October 2022
Polycystic Ovary Syndrome and the Risk of Endometrial Cancer
Keywords: PCOS; Endometrial Hyperplasia; Endometrial Cancer; Unopposed Estrogen Effect; Progesterone Resistance; Endometrial Mesenchymal Stroma/Stem Cells; Obesity; Insulin Resistance; Hyperandrogenism; Inflammation
Editor: Masuma Khatun, PhD
Submission deadline: 24 June 2023
The Management of Endometrial Cancer
Keywords: Endometrial Cancer; High-risk Factors; Adjuvant Treatment; Endocrine Therapy; Targeted Therapy
Editor: Nicolae Gica, MD, PhD,Yoland Antill, BMed FRACP MD
Submission deadline: 31 July 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.